Pharmacists, as well as patients, are now able to quickly obtain details of clinical trials for new medicines in development via a new Web site established by the pharmaceutical industry. This Internet site, www.ifpma.org/ clinicaltrials, provides detailed information about most, but not all, clinical studies under way by the global pharmaceutical industry. By making this information more easily accessible to the public, drugmakers hope to allay consumer concerns over the safety of new pharmaceuticals.
Those concerns spiked earlier this year following the withdrawal of Vioxx and disclosures of serious side effects associated with other pain medications on the market. Created by the International Federation of Pharmaceutical Manufacturers and Associations, the new Web site is designed to enable patients to learn about opportunities to participate in clinical trials for drugs being studied to treat their conditions.
Mr. Rankin is a freelance medical writer.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs